BIO vs TREE · rev $2.58B vs P/E 2.8, rev $900.2M
BIO (BIO) versus Lendingtree Inc (TREE) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
BIO currently screens at market cap $0. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Not investment advice. Open the BIO and TREE stock pages for the full models.
Not investment advice.